Equipment
All of the flow cytometry analyses were performed on an Attune NxT Flow Cytometer.
Images of protein gels including coomassie SDS-PAGE gel and western blotting membrane were taken on ChemiDoc XRS+ (Bio-Rad). Absorbance, fluorescence intensity and luminescence were monitored in a Multi-Mode Microplate Reader (Synergy TM H4, Bio-Tek). Confocal images were taken on a Nikon spinning disk confocal microscope (TE2000). Fluorescent and phase contrast microscope images were taken on an All-In One fluorescence microscope (Keyence, BZ-X700). Bioluminescence imaging of live mice were acquired using an IVIS Spectrum system.
Cells
Cell lines were all purchased from ATCC unless otherwise specified. CHO cell lines (WT, 
Supplementary Methods

One-pot protocol for producing GDP-Fucose derivatives
Reactions were typically carried out in a 15 mL corning tube with 5 mL 100 mM HEPES buffer (pH 7.5) containing L-fucose analogues (final concentration, 10 mM), ATP (10 mM), GTP (10 mM), MgSO4 (10 mM), KCl (50 mM), inorganic pyrophosphatase (90 units, ~0.17 g/L, endotoxin free), and FKP (9 units, ~0.6 g/L, endotoxin free). The reaction mixture was incubated at 37 °C for 5-6 h with shaking (225 rpm). After the reaction finished (monitored by TLC analysis 1 ), enzymes were precipitated by adding 5 mL cold EtOH into the crude product. After the precipitates were removed through centrifuge (8000×g, 5 min), the crude products (containing ~10 mM GDP-Fucose analogues) could be directly used. For GF-Al and GF-Az, further modification could be achieved through CuACC reaction. Crude GF-Al/GF-Az sample (~5 mM, in HEPES buffer) were reacted with azide/alkyne probes (6 mM, the information of these commercial available compounds could be found in Materials and Reagents) in the presence of Cu/BTTP (1/2, 500 μM) and sodium ascorbate (2 mM) at 30 °C for 6h (For Tz substrates, add one volume of MeOH in reaction mixture). After reaction finished (monitored by TLC and LC-MS analysis, representative figures of GF-Az-Tz and GF-AlTz are shown in Spectra part), BCS (bathocuproine sulphonate, 2 mM) were added to quench the reaction. These biocompatible crude products were lyophilized and reconstituted in pure water to a final concentration of 10 mM, which could be directly used in cell labeling. Following this protocol, we made one-pot products of GF-AlBiotin, GF-Al-Cy3, GF-Al-Tz and GF-Az-Tz. Their structures are shown in Figure S1 .
Since GF-Al-Tz and GF-Az-Tz are important starting materials for making GF-IgG, we purified these two GDP-Fucose derivatives and characterize them using high-resolution ESI-TOF MS and NMR (Spectra), which also confirm the one-pot procedure is reliable.
General procedure for enzymatic transfer of GDP-Fucose derivatives to cell surface
Live cells (1~2 million) were resuspended in 100 μL HBSS buffer containing 20 mM 
Comparison of Sortagging and Fucosylation
For sortagging reaction, NK-92MI cells (5 million/mL) were incubated with soluble SrtA and biotin-LPETG in RPMI complete media (10% inactivated fetal bovine serum, 1%
MEM (Gibco) Non-Essential Amino Acids Solution, 1 mM sodium pyruvate, 1%
GlutaMAX, (Gibco) 0.1 mM β-mercaptoethanol) supplemented with 10 mM CaCl2 at 37 °C for 2 hr 4 . For fucosylation reaction, NK-92MI cells (5 million/mL) were incubated with FucT and GF-biotin in fucosylation buffer described in Methods 2 for different times (2-30 min). Different concentrations of enzymes and substrates were used as indicated.
Preparation of GDP-Fucose modified antibodies
All of the antibodies (full-length IgG, MW: ~150 KDa) for conjugation were first desalted into PBS and concentrated to a 6 mg/mL solution. TCO group was first introduced onto antibodies according to the standard labeling protocol of TCO-PEG4- 
General procedure for enzymatic transfer of GF-IgG to cell surface
Live cells (1~2 million) were resuspended in 100 μL HBSS buffer containing 20 mM μL SDS loading buffer and loaded to one lane of a SDS-PAGE gel. In the same gel, 1 ng, 5ng and 10ng pure GF-IgG-A647 proteins were loaded on separated lanes as the references. The resolved fluorescent gel was analyzed by ChemiDoc XRS+ (Bio-Rad). In brief, a linear plot was generated from the reference protein intensities and the quantity of IgG labeled on 2×10 5 Lec2 cells was then derived by cross-referencing its intensity, which is 12.6 ng. As the MW of IgG is around 150KDa, we can calculate the total IgG numbers labeled on 2×10 5 Lec2 cells were (12.6×10 -9 /150,000) ×6.02×10 23 =5×10 10 .
Then, each Lec2 cell has (5×10 10 )/(2×10 5 )=2.5×10 5 IgG molecules.
Primary human T cells preparation and IgG labeling on their surface
Fresh PBMCs were freshly prepared as described above. 4 million per mL PBMCs were cultured in T cell culture media with 15 ng/mL rhIL2 and activated with human CD3/CD28 T cell activator for two days. After that, activated human T cells were kept under 4×10 6 cells/mL in T cell culture media (fresh media with cytokine were added every two days). Phenotypes were characterized after two weeks expansion (>95% are human T cells). LacNAc levels on CD4+ and CD8+ T cells were tracked through fucosylation with GF-biotin on day 0 (naïve T cells), day 2, day 4, day 7, day 11 and day 13. Activated human T cells were labeled with mIgG using the general procedure for enzymatic GF-IgG transfer. After that, the labeling detection was confirmed. 
FACS and imaging analysis of binding between NK-92MI and BT474
For flow cytometry analysis, NK-92MI cells were stained with CFSE and then labeled were sacrificed and the lungs were collect for bioluminescence analysis.
Primary OT-1 CD8+ T cells preparation and IgG labeling on their surface
Splenocytes from OT-1 mice were activated by 1nM OVA peptides in T cell media for two days. After that, activated cells were in vitro expanded in fresh T cell media with 15 ng/mL rhIL2 or 10 ng/mL rhIL7 and 20 ng/mL rhIL15 for several days (kept under 8×10 6 cells/mL, fresh media with cytokine were added every two days). Phenotypes were characterized (>95% are OT-1 CD8+ T cells). LacNAc levels on OT-1 T cells (cultured with two different cytokines) were tracked through fucosylation with GF-biotin on day 0 (naïve T cells), day 2, day 4, day 7, day 9, day 11 and day 13. Activated OT-1 T cells
were labeled with α-PD-L1 and mIgG control using the general procedure for enzymatic GF-IgG transfer. After that, the labeling detection and the antigen (PD-L1-hFc) binding were both confirmed. Labeled OT-1 T cells were then cultured in T cell culture media at a start cell density of 5×10 5 cells/mL. The decay of cell surface α-PD-L1 molecule was tracked in 24 hours after labeling (anti-rat IgG staining).
OT-1 T cells re-stimulation using OVA-pulsed splenocytes
Splenocytes from B6 WT mice were pulsed with SIINFEKL (OVA) peptide (1 μg/mL, in T cell media) for 2h. After that, cells were washed three times before use. OT-1 T cells with CD45.1 congenic marker were stained with CFSE and then labeled with rIgG. 10 5
OT-1 T cells (labeled or unlabeled) were mixed with 10 6 OVA-pulsed splenocytes in 500 μL T cell media. Control groups were also set up without splenocytes. The cell mixtures were cultured for 3 days. After that, cells were stained with APC anti-CD45.1 and DAPI.
The CFSE dilution signals were analyzed on live CD45.1 positive cells.
Analysis of OT-1 CD8+ T cells mediated cytotoxicity against B16-OVA
B16-OVA cells (stably transduced with firefly luciferase) were seeded in 96-well plate and treated with 10 ng/mL IFN-γ overnight (B16-OVA cells were all treated with IFN-γ to induce high expression level of PD-1 in this work). Labeled or unlabeled OT-1 cells were co-cultured with B16-OVA cancer cells at indicated effector/target ratios for 3 hours or 20 hours in a 96-well plate (free anti-PD-L1 was added at 5 μg/ml when indicated). In most of the experiments, the effector/target ratio is 5/1. Phenotype of T cell clusters was imaged before cell number quantification. B16-OVA cell numbers were quantified through the luciferase activity according to the reference. The detection reagent was directly added to medium in each well according to the manufactory's manual (Bright-Glo, Promega). For cytokine secretion quantification, cells were cultured for 9 hours and supernatant were collected and subjected to TNF-α and IFN-γ ELISA kit.
For OT-1 T cells proliferation in killing B16-OVA, OT-1 cells were stained by CFSE before IgG labeling. Modified cells were mixed with B16-OVA cells in the effector/target ratio of 2/1. After 72 hours, the cell mixtures were stained with APC-anti CD8 and DAPI.
CFSE dilution signal was analyzed on CD8+ cells.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism software (version 7.0).
Comparisons over groups were analyzed using two-way ANOVA tests followed by
Sidak's multiple comparisons test, and comparisons of multiple samples at one group were analyzed using one-way ANOVA followed by Tukey's multiple comparisons test.
For cell-based experiments, three biological replicates were performed. For tumor experiments in NSG mice, each group has 10 mice. In all figures, ns, P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001 
